203 related articles for article (PubMed ID: 8554067)
21. Mutation analysis of the BRCA1 gene in ovarian cancers.
Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA
Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717
[TBL] [Abstract][Full Text] [Related]
22. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
Górski B; Byrski T; Huzarski T; Jakubowska A; Menkiszak J; Gronwald J; Pluzańska A; Bebenek M; Fischer-Maliszewska L; Grzybowska E; Narod SA; Lubiński J
Am J Hum Genet; 2000 Jun; 66(6):1963-8. PubMed ID: 10788334
[TBL] [Abstract][Full Text] [Related]
23. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
Neuhausen SL; Mazoyer S; Friedman L; Stratton M; Offit K; Caligo A; Tomlinson G; Cannon-Albright L; Bishop T; Kelsell D; Solomon E; Weber B; Couch F; Struewing J; Tonin P; Durocher F; Narod S; Skolnick MH; Lenoir G; Serova O; Ponder B; Stoppa-Lyonnet D; Easton D; King MC; Goldgar DE
Am J Hum Genet; 1996 Feb; 58(2):271-80. PubMed ID: 8571953
[TBL] [Abstract][Full Text] [Related]
24. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton DF; Ford D; Bishop DT
Am J Hum Genet; 1995 Jan; 56(1):265-71. PubMed ID: 7825587
[TBL] [Abstract][Full Text] [Related]
25. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.
Håkansson S; Johannsson O; Johansson U; Sellberg G; Loman N; Gerdes AM; Holmberg E; Dahl N; Pandis N; Kristoffersson U; Olsson H; Borg A
Am J Hum Genet; 1997 May; 60(5):1068-78. PubMed ID: 9150154
[TBL] [Abstract][Full Text] [Related]
26. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.
Gayther SA; Warren W; Mazoyer S; Russell PA; Harrington PA; Chiano M; Seal S; Hamoudi R; van Rensburg EJ; Dunning AM; Love R; Evans G; Easton D; Clayton D; Stratton MR; Ponder BA
Nat Genet; 1995 Dec; 11(4):428-33. PubMed ID: 7493024
[TBL] [Abstract][Full Text] [Related]
27. BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.
Sarantaus L; Auranen A; Nevanlinna H
Int J Oncol; 2001 Apr; 18(4):831-5. PubMed ID: 11251181
[TBL] [Abstract][Full Text] [Related]
28. Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.
Essioux L; Girodet C; Sinilnikova O; Pagès S; Eisinger F; de Résende S; Maugard C; Lanoë D; Longy M; Bignon YJ; Sobol H; Bonaïti-Pellié C; Stoppa-Lyonnet D
Am J Med Genet; 1998 Sep; 79(3):175-83. PubMed ID: 9788557
[TBL] [Abstract][Full Text] [Related]
29. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
30. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
[TBL] [Abstract][Full Text] [Related]
31. Rapid detection of BRCA1 mutations by the protein truncation test.
Hogervorst FB; Cornelis RS; Bout M; van Vliet M; Oosterwijk JC; Olmer R; Bakker B; Klijn JG; Vasen HF; Meijers-Heijboer H
Nat Genet; 1995 Jun; 10(2):208-12. PubMed ID: 7663517
[TBL] [Abstract][Full Text] [Related]
32. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.
Friedman LS; Ostermeyer EA; Szabo CI; Dowd P; Lynch ED; Rowell SE; King MC
Nat Genet; 1994 Dec; 8(4):399-404. PubMed ID: 7894493
[TBL] [Abstract][Full Text] [Related]
33. Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancer.
Santarosa M; Viel A; Dolcetti R; Crivellari D; Magri MD; Pizzichetta MA; Tibiletti MG; Gallo A; Tumolo S; Del Tin L; Boiocchi M
Int J Cancer; 1998 Nov; 78(5):581-6. PubMed ID: 9808526
[TBL] [Abstract][Full Text] [Related]
34. Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer.
Cornelis RS; Vasen HF; Meijers-Heijboer H; Ford D; van Vliet M; van Tilborg AA; Cleton FJ; Klijn JG; Menko FH; Meera Khan P
Hum Genet; 1995 May; 95(5):539-44. PubMed ID: 7759075
[TBL] [Abstract][Full Text] [Related]
35. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.
Biesecker BB; Boehnke M; Calzone K; Markel DS; Garber JE; Collins FS; Weber BL
JAMA; 1993 Apr; 269(15):1970-4. PubMed ID: 8352830
[TBL] [Abstract][Full Text] [Related]
36. Progress toward isolation of a breast cancer susceptibility gene, BRCA1.
Weber BL; Abel KJ; Couch FJ; Merajver SD; Chandrasekharappa SC; Castilla L; McKinley D; Ho PP; Calzone K; Frank TS
Cold Spring Harb Symp Quant Biol; 1994; 59():531-6. PubMed ID: 7587109
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation.
Matsushima M; Kobayashi K; Emi M; Saito H; Saito J; Suzumori K; Nakamura Y
Hum Mol Genet; 1995 Oct; 4(10):1953-6. PubMed ID: 8595420
[TBL] [Abstract][Full Text] [Related]
38. Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.
Chang-Claude J; Dong J; Schmidt S; Shayeghi M; Komitowski D; Becher H; Stratton MR; Royer-Pokora B
J Med Genet; 1998 Feb; 35(2):116-21. PubMed ID: 9507390
[TBL] [Abstract][Full Text] [Related]
39. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
Byrski T
Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
[TBL] [Abstract][Full Text] [Related]
40. Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group.
Gayther SA; Harrington P; Russell P; Kharkevich G; Garkavtseva RF; Ponder BA
Am J Hum Genet; 1996 Mar; 58(3):451-6. PubMed ID: 8644703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
